Blood Test Could Predict Cancer Risk in Type 2 Diabetes Patients
A blood test measuring IL-6 levels may help identify those with type 2 diabetes who are at high risk of developing obesity-related cancers.
Read MorePosted by Andy Lundin | Aug 30, 2024 | Diabetes & Metabolic Diseases |
A blood test measuring IL-6 levels may help identify those with type 2 diabetes who are at high risk of developing obesity-related cancers.
Read MorePosted by Andy Lundin | Aug 13, 2024 | Cardiovascular |
A study reveals that lipid panels may not fully capture the risk of cholesterol-related heart disease, highlighting a need for apoB testing.
Read MorePosted by Chris Wolski | Jul 3, 2024 | Specimen Collection & Handling |
Lab values predict the risk of periprosthetic joint infection (PJI) in severely obese patients undergoing knee or hip replacement.
Read MorePosted by Chris Wolski | May 16, 2024 | Diabetes & Metabolic Diseases |
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Gastrointestinal Infections |
Lucid Diagnostics announced that a prospective VA screening study demonstrated strong performance of its EsoGuard Esophageal DNA test.
Read More